Equities research analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “buy” rating on the stock.
Mannatech Stock Down 1.1 %
MTEX opened at $14.73 on Friday. Mannatech has a 52 week low of $6.75 and a 52 week high of $15.25. The business has a 50 day moving average price of $9.92 and a two-hundred day moving average price of $8.26. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. The company has a market cap of $27.77 million, a PE ratio of -18.18 and a beta of 1.04.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The company had revenue of $31.73 million for the quarter.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Read More
- Five stocks we like better than Mannatech
- What is the Shanghai Stock Exchange Composite Index?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Industrial Products Stocks Investing
- Nebius Group: The Rising Star in AI Infrastructure
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
